quinoline has been researched along with Disease Models, Animal in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 13 (68.42) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Chandrakar, P; Gupta, S; Kar, S; Kushwaha, P; Parmar, N; Rashid, M; Sashidhara, KV; Singh, SK; Upadhyay, A; Wahajuddin, M | 1 |
| Antinarelli, LMR; Coelho, EAF; Coimbra, ES; Lima, WP; Souza, MVN | 1 |
| Delgado, G; Granados-Falla, DS; Murillo, J; Robledo, SM; Torres Suarez, E; Upegui, Y | 1 |
| Albert, N; Ben Yaakov, D; Kontoyiannis, DP; Osherov, N; Shadkchan, Y | 1 |
| Ferreira, AT; Luchese, C; Pinz, MP; Reis, ASD; Stein, AL; Vogt, AG; Wilhelm, EA; Zeni, G | 1 |
| Chen, Y; Chen, Z; He, Q; Huang, G; Huang, Z; Wang, X | 1 |
| Barros-Aguirre, D; Bates, RH; Fang, C; Fernandez-Menendez, R; Fisher, S; Gomez, JE; Guijarro-Lopez, L; Hubbard, BK; Hung, DT; Lee, KK; Lopez-Roman, EM; Nietupski, R; Peng, Z; Serrano-Wu, MH; Yin, Y | 1 |
| Faist, J; Hochegger, P; Kaiser, M; Mäser, P; Saf, R; Seebacher, W; Weis, R | 1 |
| Casalena, G; Du, G; Fontán, L; Fu, M; Gray, NS; Hatcher, JM; Liu, H; Melnick, A; Qiao, Q; Scott, DA; Us, I; Wu, H | 1 |
| Gali, H; Li, Q; Mohammed, A; Pathuri, G; Pento, JT; Rao, CV | 1 |
| Chen, TC; Cho, HY; Golden, EB; Hofman, FM; Louie, SG; Schönthal, AH | 1 |
| Chan, AS; Chan, D; Chan, SH; Chui, CH; Chung, PY; Lam, AK; Lam, KH; Law, S; Pun, IH; Tang, JC; Zhou, YY | 1 |
| Del Río, J; Frechilla, D; Salazar-Colocho, P | 1 |
| Berridge, MV; Chia, EW; Copp, BR; Denny, WA; Godfrey, CA; Hanton, LR; Harper, JL; Larsen, L; Lu, GL; Pearce, AN; Perry, NB; Sansom, CE; Walton, M; Webb, VL | 1 |
| Bilodeau, MT; Burgey, CS; Della Penna, K; Desai, R; Hartman, GD; Henze, DA; Kane, SA; Leitl, MD; Lemaire, W; Manley, PJ; Paone, DV; Trotter, BW; Urban, MO; White, RB; Yeh, S; Zartman, A | 1 |
| Bintz, B; Emerich, DF; Fjord-Larsen, L; Jørgensen, JR; Thanos, C; Tornøe, J; Torp, M; Wahlberg, LU | 1 |
| Arancio, O; Deng, SX; Feng, Y; Fiorito, J; Francis, YI; Landry, DW; Rao, S; Saeed, F; Staniszewski, A; Thakkar, DM; Zhang, H | 1 |
| Matsuo, M; Nishimura, H; Ogino, T; Seki, N; Spears, GW; Sugiyama, A; Tojo, T; Tsuji, K | 1 |
| Cha, JH; Chang, DJ; Choi, EC; Jung, HY; Kim, KW; Kim, MJ; Kim, SH; Kwon, DY; Lee, J; Li, F; Lim, SH; Park, CH; Suh, YG; Yeo, HT; Yoon, EJ | 1 |
19 other study(ies) available for quinoline and Disease Models, Animal
| Article | Year |
|---|---|
Synthesis, Biological Evaluation, Structure-Activity Relationship, and Mechanism of Action Studies of Quinoline-Metronidazole Derivatives Against Experimental Visceral Leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Disease Models, Animal; Leishmania donovani; Leishmaniasis, Visceral; Metronidazole; Quinolines; Rats; Structure-Activity Relationship; Tissue Distribution; Vero Cells | 2019 |
Efficacy of the 7-chloro-4-(3-hydroxy-benzilidenehydrazo)quinoline derivative against infection caused by Leishmania amazonensis.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Leishmania mexicana; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Parasite Load; Quinolines | 2020 |
Antileishmanial activity of synthetic analogs of the naturally occurring quinolone alkaloid N-methyl-8-methoxyflindersin.
Topics: Alkaloids; Animals; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Heterocyclic Compounds, 3-Ring; Humans; Leishmania guyanensis; Leishmaniasis, Cutaneous; Macrophages; Mice; Nitric Oxide; Plant Leaves; Quinolines; Quinolones; Rutaceae | 2020 |
The quinoline bromoquinol exhibits broad-spectrum antifungal activity and induces oxidative stress and apoptosis in Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Apoptosis; Aspergillosis; Aspergillus fumigatus; Aspergillus nidulans; Disease Models, Animal; Lepidoptera; Microbial Sensitivity Tests; Oxidative Stress; Quinolines; Survival Analysis | 2017 |
Antioxidant effect of quinoline derivatives containing or not selenium: Relationship with antinociceptive action quinolines are antioxidant and antinociceptive.
Topics: Analgesics; Animals; Antioxidants; Disease Models, Animal; Free Radical Scavengers; Male; Mice; Oxidation-Reduction; Oxidative Stress; Oxidoreductases Acting on Sulfur Group Donors; Pain Measurement; Porphobilinogen Synthase; Quinolines; Selenium | 2017 |
The protection of novel 2-arylethenylquinoline derivatives against impairment of associative learning memory induced by neural Aβ in C. elegans Alzheimer's disease model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Association Learning; Caenorhabditis elegans; Disease Models, Animal; Memory; Neuroprotective Agents; Quinolines | 2017 |
Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Coumarins; Disease Models, Animal; Drug Evaluation, Preclinical; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinolines; Structure-Activity Relationship; Tuberculosis | 2018 |
Synthesis and structure-activity relationships for new 6-fluoroquinoline derivatives with antiplasmodial activity.
Topics: Animals; Antimalarials; Cell Line; Cell Survival; Disease Models, Animal; Drug Resistance; Malaria; Mice; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2019 |
Quinoline and thiazolopyridine allosteric inhibitors of MALT1.
Topics: Animals; Disease Models, Animal; Humans; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein; Quinolines | 2019 |
Synthesis and in vivo evaluation of N-ethylamino-2-oxo-1,2-dihydro-quinoline-3-carboxamide for inhibition of intestinal tumorigenesis in APC(Min/+) mice.
Topics: Adenomatous Polyposis Coli; Amides; Animals; Antineoplastic Agents; Carcinogenesis; Colonic Neoplasms; Disease Models, Animal; Female; Humans; Male; Mice; Protein Kinase Inhibitors; Quinolines; Receptor, Fibroblast Growth Factor, Type 2 | 2014 |
Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors.
Topics: Animals; Antimalarials; Antineoplastic Agents; Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; Glioma; Humans; Mice, Nude; Poly(ADP-ribose) Polymerases; Quinolines; Xenograft Model Antitumor Assays | 2015 |
Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Ligands; Mice; Models, Molecular; Molecular Conformation; Protein Binding; Quinolines; RNA, Messenger; Xenograft Model Antitumor Assays | 2017 |
Involvement of the vascular wall in regenerative processes after CA1 ischemic neuronal death.
Topics: Adult Stem Cells; Animals; Antigens; Bromodeoxyuridine; Cell Death; Cell Proliferation; Cerebral Arteries; Disease Models, Animal; Fibroblast Growth Factor 2; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Male; Microscopy, Confocal; Nerve Tissue Proteins; Neurons; Quinolines; Vascular Endothelial Growth Factor A; Vimentin; von Willebrand Factor | 2008 |
Synthesis and anti-inflammatory structure-activity relationships of thiazine-quinoline-quinones: inhibitors of the neutrophil respiratory burst in a model of acute gouty arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Cell Proliferation; Disease Models, Animal; HL-60 Cells; Humans; Inflammation; Male; Mice; Mice, Inbred C57BL; Neutrophils; Quinolines; Quinones; Respiratory Burst; Structure-Activity Relationship; Superoxides; Thiazines | 2008 |
Decahydroquinoline amides as highly selective CB2 agonists: role of selectivity on in vivo efficacy in a rodent model of analgesia.
Topics: Amides; Analgesics; Animals; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Pain; Quinolines; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2011 |
Encapsulated cell-based biodelivery of meteorin is neuroprotective in the quinolinic acid rat model of neurodegenerative disease.
Topics: Absorbable Implants; Animals; Brain Tissue Transplantation; Capsules; Cell Line; Cytoprotection; Disease Models, Animal; Humans; Huntington Disease; Male; Mice; Nerve Growth Factors; Nerve Tissue Proteins; Neuroprotective Agents; Quinolines; Rats; Rats, Sprague-Dawley | 2012 |
Synthesis of quinoline derivatives: discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Drug Discovery; Female; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Phosphodiesterase 5 Inhibitors; Quinolines | 2013 |
Quinoline-3-carbothioamides and related compounds as novel immunomodulating agents.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Antibody Formation; Autoimmune Diseases; Disease Models, Animal; Dogs; Graft vs Host Disease; Half-Life; Immunization; Mice; Nephritis; Proteinuria; Quinolines; Structure-Activity Relationship; Thioamides | 2002 |
Identification, biological activity, and mechanism of the anti-ischemic quinolone analog.
Topics: Animals; Anti-Bacterial Agents; Brain Ischemia; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Humans; Models, Biological; Molecular Structure; Myocardial Infarction; Quinolines; Rats; Structure-Activity Relationship | 2007 |